Stay updated with breaking news from Cell Genesys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Charlene Banard, Gerard Fleury, Evan Greger, and Carson Sublett will help accelerate the progress of Matica Bio's cell and gene therapy manufacturing, operations, and business strategy.COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organizat...
/cloudfront-us-east-1.images.arcpublishing.com/tgam/FNOPY3Q7DBMQHMNKRU4USZ2AS4.JPG)
Tentarix is developing biologic therapies that target specific cells in the body and could be used to fight cancer and autoimmune diseases while limiting side effects
/cloudfront-us-east-1.images.arcpublishing.com/tgam/IRATQROOEBKBJLVJPCBZATLKIM.JPG)
The U.S. drug giant will pay Tentarix Biotherapeutics Inc. US$66-million upfront and the pair will partner on three development programs
/PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief...
SAN DIEGO--(BUSINESS WIRE)--Ambrx Biopharma, Inc., or Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using its proprietary Engineered Precision Biologics (EPBs) platform to create antibody-drug conjugates (ADCs), has appointed Sandra Aung, Ph.D., as Executive Vice President, Head of Clinical Developm...